Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia Nabs US FDA 510(k) Clearance for Digital Pathology Software

Proscia
By Author Proscia | February 12, 2024

Proscia said it has secured US Food and Drug Administration 510(k) clearance for its digital pathology software that is used to aid in the viewing, management, and interpretation of whole slide images. Concentriq AP-Dx is designed for use in clinical settings ranging from reference laboratories to large hospital systems and helps to drive quality and efficiency gains.

Our website uses cookies. By using this site, you agree to its use of cookies.